Nanni Huser
Impact in
- Molecular Biology top 10%
- Protein Kinase Regulation and GTPase Signaling
- Heat shock proteins research
- PI3K/AKT/mTOR signaling in cancer
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- DNA Repair Mechanisms 2
- Oncology 8
- Cancer-related Molecular Pathways 4
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Adam Siddiqui-Jain (7 shared papers)Denis Drygin (8 shared papers)William G. Rice (7 shared papers)Sean O’Brien (6 shared papers)Kenna Anderes (6 shared papers)Chris Proffitt (5 shared papers)David M. Ryckman (5 shared papers)Nicole Streiner (6 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)Cancer Research (3 papers)Neoplasia (1 paper)ACS Medicinal Chemistry Letters (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Nanni Huser
15 papers receiving 983 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 737
- Oncology 238
- Genetics 82
- Hematology 68
- Cancer Research 84
Countries citing papers authored by Nanni Huser
This map shows the geographic impact of Nanni Huser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanni Huser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanni Huser more than expected).
Fields of papers citing papers by Nanni Huser
This network shows the impact of papers produced by Nanni Huser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanni Huser. The network helps show where Nanni Huser may publish in the future.
Co-authors
The 25 scholars most cited alongside Nanni Huser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 421 | |
| 2 | 2009 | 140 | |
| 3 | 2012 | 114 | |
| 4 | 2017 | 95 | |
| 5 | 2012 | 86 | |
| 6 | 2012 | 59 | |
| 7 | 2017 | 49 | |
| 8 | 2017 | 16 | |
| 9 | 2024 | 6 | |
| 10 | 2011 | 4 | |
| 11 | In vitro and in vivo antitumor activities of SGX523, a novel MET inhibitor | 2007 | 3 |
| 12 | 2010 | 3 | |
| 13 | 2024 | 1 | |
| 14 | 2009 | 1 | |
| 15 | 2011 | 1 |
About Nanni Huser
Nanni Huser is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hematology and Cell Biology, having authored 15 papers that have together received 999 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (2 papers), Cancer Treatment and Pharmacology (2 papers), Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Molecular Biology (737 citations), Oncology (238 citations), Genetics (82 citations), Hematology (68 citations) and Cancer Research (84 citations). Nanni Huser has collaborated with scholars based in United States and Australia. Frequent co-authors include Adam Siddiqui-Jain, Denis Drygin, William G. Rice, Sean O’Brien, Kenna Anderes, Chris Proffitt, David M. Ryckman, Nicole Streiner, Caroline B. Ho and Mayuko Omori. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Neoplasia, ACS Medicinal Chemistry Letters and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.